| |
| |
|
| Insider
Information: |
Ordentlich Peter |
| Relationship: |
|
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -54.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Syndax Pharmaceuticals Inc |
SNDX |
|
2023-02-15 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| SNDX |
Syndax Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2023-02-15 |
4 |
AS |
$25.84 |
$646,093 |
D/D |
(25,000) |
0 |
0 |
% |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2023-02-15 |
4 |
OE |
$6.38 |
$173,791 |
D/D |
25,000 |
17,428 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2023-02-01 |
4 |
S |
$28.43 |
$1,962 |
D/D |
(69) |
0 |
0 |
% |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2023-01-31 |
4 |
A |
$17.32 |
$1,195 |
D/D |
69 |
69 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2022-12-02 |
4 |
OE |
$6.38 |
$109,736 |
D/D |
17,200 |
17,465 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2022-12-02 |
4 |
AS |
$25.05 |
$430,936 |
D/D |
(17,200) |
265 |
0 |
% |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2022-12-01 |
4 |
AS |
$25.01 |
$195,089 |
D/D |
(7,800) |
265 |
0 |
% |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2022-12-01 |
4 |
OE |
$6.35 |
$49,651 |
D/D |
7,800 |
4,293 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2022-08-24 |
4 |
AS |
$25.04 |
$625,893 |
D/D |
(25,000) |
265 |
0 |
% |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2022-08-24 |
4 |
OE |
$6.32 |
$158,065 |
D/D |
25,000 |
2,419 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2022-07-29 |
4 |
A |
$14.12 |
$3,742 |
D/D |
265 |
265 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2022-02-01 |
4 |
S |
$16.65 |
$23,510 |
D/D |
(1,412) |
0 |
0 |
% |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2022-01-31 |
4 |
A |
$12.39 |
$17,495 |
D/D |
1,412 |
1,412 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2020-11-23 |
4 |
S |
$22.89 |
$694,121 |
D/D |
(29,972) |
0 |
0 |
% |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2020-11-23 |
4 |
OE |
$3.08 |
$92,314 |
D/D |
29,972 |
29,972 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2018-04-03 |
4 |
OE |
$3.08 |
$23,100 |
D/D |
7,500 |
7,500 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2018-04-03 |
4 |
AS |
$15.00 |
$112,500 |
D/D |
(7,500) |
0 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2017-05-17 |
4 |
AS |
$15.00 |
$75,000 |
D/D |
(5,000) |
0 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Scientific Officer |
• – – |
2017-05-17 |
4 |
OE |
$3.08 |
$2,255 |
D/D |
732 |
5,000 |
0 |
- |
|
| SNDX |
Syndax Pharmaceuticals In... |
Chief Technology OfficerOffice |
• – – |
2016-03-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,268 |
|
- |
|
20 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
